Inhibition of nuclear factor-κB-mediated adhesion molecule expression in human endothelial cells

Circulation Research

Volumn 82, Issue 3, 1998, Pages 314-320

  Lockyer, Jean M ^a   Colladay, John S ^a   Alperin Lea, Wendy L ^a   Hammond, Timothy ^a,b   Buda, Andrew J ^a  

^a TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Adhesion molecule; Gene expression; Inflammation; Nuclear factor B; Vascular endothelium

Indexed keywords

CELL ADHESION MOLECULE; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERCELLULAR ADHESION MOLECULE 1; SYNAPTOTAGMIN; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CELL POPULATION; DNA BINDING; ENDOTHELIUM CELL; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENE TRANSFER; GENETIC TRANSDUCTION; HUMAN; HUMAN CELL; IMMUNE RESPONSE; INFLAMMATION; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RETROVIRUS; VASCULAR ENDOTHELIUM;

EID: 0032559561     PISSN: 00097330     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.RES.82.3.314     Document Type: Article

References (34)

1. Springer TA. Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm. Cell. 1994;76:301-314.
2. Read MA, Neish AS, Luscinskas FW, Palombella VJ. Maniatis T, Collins T. The proteasome pathway is required for cytokine-induced endothelial-leukocyte adhesion molecule expression. Immunity. 1995;2:493-506.
3. Schindler U, Baichwal VR. Three NF-κB binding sites in the human E-selectin gene required for maximal tumor necrosis factor alpha-induced expression. Mol Cell Biol. 1994;14:5820-5831.
4. Whitley M, Thanos D, Read M, Maniatis T, Collins T, A strikingly similarity in the organization of the E-selectin and beta Interferon gene promoters. Mol Cell Biol. 1994;14:6464-6475.
5. Iademarco MF, McQuilIan JJ, Dean DC. Vascular cell adhesion molecule 1: contrasting transcriptional control mechanisms in muscle and endothelium. Proc Natl Acad Sci U S A. 1993;90:3943-3947.
6. Marui N, Offermann MK, Swerlick R, Kunsch C, Rosen CA. Ahmad M, Alexander RW, Medford RM. Vascular cell adhesion molecule-1 (VCAM-1) gene transcription and expression are regulated through an antioxidam-sensitive mechanism in human vascular endothelial cells. J Clin Invest. 1993;92:1866-1874.
7. Neish AS, Williams AJ, Palmer HJ, Whitley MZ, Collins T. Functional analysis of the human vascular cell adhesion molecule 1 promoter. J Exp Med. 1992;176:1583-1593.
8. Ledebur HC, Parks TP. Transcriptional regulation of the intercellular adhesion molecule-1 gene by inflammatory cytokines in human endothelial cells. J Biol Chem. 1995;270:933-943.
9. Wrighton CJ, Hofer-Warbinek R, Moll T, Eytner R, Bach FH, de Martin R. Inhibition of endothelial cell activation by adenovirus-mediated expression of IkBa, an inhibitor of the transcription factor NF-κB. J Exp Med. 1996;183:1013-1022.
10. Baeuerle PA, Baltimore D. IκB: a specific inhibitor of the NF-κB transcription factor. Science. 1988;242:540-546.
11. Beg AA, Ruben SM, Scheinman RI, Haskill S, Rosen CA, Baldwin AS Jr. 1κB interacts with the nuclear localization sequences of the subunits ot' NF-KB: a mechanism for cytoplaimic retention. Genes Dev. 1992;6: 1899-1913.
12. Haskill S, Beg AA, Tompkins SM, Morris JS, Yurochko AD, SampsonJohannes A. Mondai K, Ralph P, Baldwin AS Jr. Characterization of an immediate-early gene induced in adherent monocytes that encodes IκB-like activity. Cell. 1991;65:1281-1289.
13. Thanos D, Maniatas T, NF-κB: a lesson in family values. Cell. 1995;80: 529-532.
14. Verma IM, Stevenson JK, Schwarz EM, Antwerp D, Miyamotos S. Rel/ NF-κB/lκB family: intimate tales of association and dissociation. Giros Dev. 1996;9:2723-2735.
15. Brown K, Gerstberger S, Carlson L, Fmnzoso G, Sienbenlist U. Control of IκB-α proteolysis by site-specific, signal-induced phosphorylation. Science. 1995; 267:1485-1488.
16. Jung M. Zhang Y, Lee S, Dritschilo A. Correction of radiation sensitivity in ataxia telangiectasia cells by a truncated IκB-α. Science. 1995;268; 1619-1621.
17. Brockman JA, Scherer DC, McKinsey TA. Hall SM, Qi X, Lee WY, Ballard DW. Coupling of a signal response domain in IκBα to multiple pathways for NF-κB activation. Mol Cell Biol. 1995;15:2809-2818.
18. Sun S-C, Elwood J, Greene WC. Both amino- and carboxyl-terminal sequences within IκBa regulate its inducible degradation. Mol Cell Biol. 1996;16:1058-1065.
19. Traenckner EB, Wilk S, Baeuerle PA. A proteasome inhibitor prevents activation of NF-κB and stabilizes a newly phosphorylated form of IκB-α that is still bound to NF-κB. EMBO J. 1994;13:5433-3441.
20. Traenckner EB-M, Pahl HL, Henkel T, Schmidt KN. Wilk S, Baeuerle PA. Phosphorylation of human IκB-a on serines 32 and 36 controls IκB-a proteolysis and NF-κB activation in response to diverse stimuli. EMBO J. 1995;14:2876-2883.
21. Miller AD, Rosman GJ, Improved retroviral vectors for gene transfer and expression. Biotechniques. 1989;7:980-990.
22. Lockyer JM, McCracken JBJ. Identification of a tissue-specific regulatory element within the human muscle glycogen phosphorylase gene. J Biol Chem. 1991;266:20262-20269.
23. Prickett KS, Amberg DC, Hopp TP. A calcium-dependent antibody for identification and purification of recombinant proteins. Biotecniques. 1989; 7:580-589.
24. Schrieber E, Matthias P, Muller M, Schaffner W. Rapid detection of Detainer binding proteins with 'mini-extracts,' prepared from a small number of cells. Nucleic Acids Res. 1989;17:6419.
25. Osborn L, Kunkel S, Nabel G. tumor necrosis factor alpha and interleukin 1 stimulate the human immunodeficiency virus enhancer by activation of the nuclear factor KB. Proc Natl Acad Sci U S A. 1989;86:2336-2340.
26. Zabel U, Schreck R, Baeuerle PA. DNA binding of purified transcription factor NF-κB. J Biol Chem. 1991;266:252-260.
27. Baeuerle PA, Henkel T. Function and activation of NF-κB in the immune system. Annu Rev Immunol. 1994;12:141-179.
28. Grilli M, Chin JJ, Lenardo MJ. NF-κB and Rel: participants in a multiform transcriptional regulators' system. Int Rev Cytol. 1993;143:1-62.
29. Iademarco MF, McQuillan JJ, Rosen GD, Dean DC. Characterization of the promoter for vascular cell adhesion molecule-1 (VCAM-1). J Biol Chem. 1992;267:16323-16329.
30. Palombella VJ, Rando OJ, Goldberg AL, Maniatis T. The ubiquitin-proteasome pathway is required for processing the NF-κb1 precursor protein and the activation of NF-κB. Cell. 1994;78:773-785.
31. Schreck R, Grassman R, Fleckenstein B, Baeuerle PA. Antioxidants selectively suppress activation of NF-κB by human T-cell leukemia virus type I tax protein. J Virol. 1992;66:6288-6293.
32. Wang C-Y, Mayo MW, Baldwin AS Jr. TNF- and cancer therapy-induced apoptosis: potemiation by inhibition of NF-κB. Science. 1996;274: 784-787.
33. Van Antwerp DJ, Martin SJ, Kafri T, Green DR, Verma IM. Suppression of TNF-α-induced apoptosis by NF-κB. Science. 1996;274:787-782.
34. Beg AA, Baltimore D. An essential role for NF-κB in preventing TNF-α-induced cell death. Science. 1996;274:782-784.